Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sonal, Mehra"'
Autor:
Aishwarya Gopal, Chengappa Kavadichanda, Devender Bairwa, Sanket Shah, Sonal Mehra, Bheemanathi Hanuman Srinivas, Christina Mary Mariaselvam, Molly Mary Thabah, Vir Singh Negi
Publikováno v:
Diagnostics, Vol 12, Iss 12, p 3163 (2022)
Objectives: To assess the performance of clinical and biochemical parameters in identifying renal histopathology. To assess the performance of a combination of demographic, clinical, serological and histopathological parameters in determining renal r
Externí odkaz:
https://doaj.org/article/40f750d7f8bd44b988aa0beb6d04673f
Autor:
Sonal Mehra, Marvin J. Fritzler
Publikováno v:
Journal of Immunology Research, Vol 2014 (2014)
Autoantibodies directed to chromatin components date back to the discovery of the LE cell and the LE cell phenomenon circa 1950, and subsequent evidence that major components of that reaction were chromatin components and histones in particular. Over
Externí odkaz:
https://doaj.org/article/6056fcfab31942b3b53d98ae2428e098
Autor:
Paul T. Antony, Sonal Mehra, Reena Gulati, Vikramraj K Jain, Vir Singh Negi, Panneer Devaraju, Durga Prasanna Misra
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 147, Iss 6, Pp 560-566 (2018)
Indian Journal of Medical Research, Vol 147, Iss 6, Pp 560-566 (2018)
Background & objectives: Genetic aberrations disrupting toll-like receptor and interferon homeostasis enhance the risk of systemic lupus erythematosus (SLE). Raised serum interferon-alpha (IFN-α) levels in SLE patients have been ascribed to polymorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180c0ea17fad845b6fc15fd4c7bdff40
http://europepmc.org/articles/PMC6118151
http://europepmc.org/articles/PMC6118151
Publikováno v:
Rheumatology international. 38(4)
Cyclophosphamide (CYC) has been the backbone immunosuppressive drug to achieve sustained remission in lupus nephritis (LN). The aim was to evaluate the efficacy and compare adverse effects of low and high dose intravenous CYC therapy in Indian patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3be3ff18228a5201323b79e7c1e9b1
https://pubmed.ncbi.nlm.nih.gov/29450636
https://pubmed.ncbi.nlm.nih.gov/29450636
Autor:
Rosa M. Estrada-Y-Martin, Mandana Nikpour, Tingting Mills, Mianbo Wang, Jennifer G Walker, Wendy Stevens, Claudia Pedroza, Shervin Assassi, Marie Hudson, Murray Baron, Sonal Mehra, Susanna Proudman, Maureen D. Mayes, Carolina Mejia Otero, Marvin J. Fritzler
Publikováno v:
The Journal of rheumatology. 44(6)
Objective.To examine the clinical correlates and survival in patients with antifibrillarin antibodies (AFA) in a large international study population consisting of well-characterized systemic sclerosis (SSc) cohorts from Canada, Australia, and the Un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4374ce27631d9e982c181ec635c3666
https://pubmed.ncbi.nlm.nih.gov/28365584
https://pubmed.ncbi.nlm.nih.gov/28365584
Publikováno v:
Immunobiology. 219:465-468
Introduction Complement system is an important effector component of the innate immune system. More than 30 plasma proteins undergo a cascade of enzymatic reactions to produce effector molecules to clear infectious microbes, immune complexes, post ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0f2e3d87035d2272fa66d914685547c
https://doi.org/10.1016/j.imbio.2014.02.004
https://doi.org/10.1016/j.imbio.2014.02.004
Autor:
Robert F. Storey, Kate E Howgego, Wael Sumaya, Rosemary Ecob, Rebecca L Daly, Amrita J Dhutia, Sonal Mehra, Heather M Judge, Allison Morton
Publikováno v:
Thrombosis and Haemostasis. 109:550-555
SummaryVerifyNow (VN) P2Y12 is a point-of-care assay used to assess response to P2Y12 inhibitors. Sodium citrate (citrate) is the standard anticoagulant used for this assay but requires a pre-incubation period. Hirudin is an alternative anticoagulant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::204180069ef1d2c968f843c225e87754
https://doi.org/10.1160/th12-10-0718
https://doi.org/10.1160/th12-10-0718
Publikováno v:
Rheumatology International. 34:425-427
Autoantibodies to Ro52/TRIM21 are among the most common autoantibodies detected in subjects with systemic autoimmune rheumatic autoimmune diseases (SARD), including systemic sclerosis (SSc) [1–3]. Ro52/TRIM21 is an immunoglobulin-binding protein [4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fe0688e5e0b2ca0c3a3108f8818c2c9
https://doi.org/10.1007/s00296-013-2728-x
https://doi.org/10.1007/s00296-013-2728-x
Publikováno v:
JCR: Journal of Clinical Rheumatology. 18:298-300
Dermatomyositis is a rare autoimmune inflammatory myopathy with proximal muscle weakness and skin affection. Only 4 cases of HIV that subsequently developed dermatomyositis have been reported. This is the first case of dermatomyositis being the initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae190e6d22ba211dfc24b408d4b48c65
https://doi.org/10.1097/rhu.0b013e318268566c
https://doi.org/10.1097/rhu.0b013e318268566c
Autor:
Anjali Rajadhyaksha, Sonal Mehra
Publikováno v:
International Journal of Rheumatic Diseases. 15:e162-e164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bafdbca1fe82972d1cb7098aa1116f0
https://doi.org/10.1111/j.1756-185x.2012.01761.x
https://doi.org/10.1111/j.1756-185x.2012.01761.x